2024

Myeloid cell-derived interleukin-6 induces vascular dysfunction and vascular and systemic inflammation

Eur Heart J open

Knopp T, Jung R, Wild J, Bochenek ML, Efentakis P, Lehmann A, Bieler T, Garlapati V, Richter C, Molitor M, Perius K, Finger S, Lagrange J, Ghasemi I, Zifkos K, Kommoss KS, Masri J, Reißig S, Randriamboavonjy V, Wunderlich T, Hövelmeyer N, Weber ANR, Mufazalov IA, Bosmann M, Bechmann I, Fleming I, Oelze M, Daiber A, Münzel T, Schäfer K, Wenzel P, Waisman A, Karbach S

10.1093/ehjopen/oeae046


Dual fluorescence reporter mice for Ccl3 transcription, translation, and intercellular communication

J Exp Med

Rodrigo MB, De Min A, Jorch SK, Martin-Higueras C, Baumgart AK, Goldyn B, Becker S, Garbi N, Lemmermann NA, Kurts C

10.1084/jem.20231814

TP11


The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells

Gut

López-Gil JC, García-Silva S, Ruiz-Cañas L, Navarro D, Palencia-Campos A, Giráldez-Trujillo A, Earl J, Dorado J, Gómez-López G, Monfort-Vengut A, Alcalá S, Gaida MM, García-Mulero S, Cabezas-Sáinz P, Batres-Ramos S, Barreto E, Sánchez-Tomero P, Vallespinós M, Ambler L, Lin ML, Aicher A, García García de Paredes A, de la Pinta C, Sanjuanbenito A, Ruz-Caracuel I, Rodríguez-Garrote M, Guerra C, Carrato A, de Cárcer G, Sánchez L, Nombela-Arrieta C, Espinet E, Sanchez-Arevalo Lobo VJ, Heeschen C, Sainz B Jr

10.1136/gutjnl-2023-330995

TPQ1, TP22


The atypical IκB family member Bcl3 determines differentiation and fate of intestinal RORγt+ regulatory T-cell subsets

Mucosal Immunology

Köhler A, Geiselhöringer AL, Kolland D, Kreft L, Wichmann N, Hils M, Pasztoi M, Zurkowski E, Vogt J, Kübelbeck T, Biedermann T, Schmitz I, Hansen W, Kramer D, Gaida MM, Schmidt-Weber CB, Hoevelmeyer N, Ohnmacht C

10.1016/j.mucimm.2024.04.002

TP20


RNA-encoded Interleukin 2 with Extended Bioavailability Amplifies RNA Vaccine-Induced Antitumor T-cell Immunity

Cancer Immunol Res

Peters D, Kranz LM, Eisel D, Diken M, Kreiter S, Türeci Ö, Sahin U, Vormehr M

10.1158/2326-6066.CIR-23-0701

TP22N


TNFR1 signaling promotes pancreatic tumor growth by limiting dendritic cell number and function

Cell Rep Med

Alam MS, Gaida MM, Witzel HR, Otsuka S, Abbasi A, Guerin T, Abdelmaksoud A, Wong N, Cam MC, Kozlov S, Ashwell JD

10.1016/j.xcrm.2024.101696

TPQ1, TP22N


Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cells

Mol Oncol

Kansy AG, Ashry R, Mustafa AM, Alfayomy AM, Radsak MP, Zeyn Y, Bros M, Sippl W, Krämer OH

10.1002/1878-0261.13638

TP21N


GSK-3ß in Dendritic Cells Exerts Opposite Functions in Regulating Cross-Priming and Memory  CD8 T Cell Responses Independent of ß-Catenin

Vaccines (Basel)

Fu C, Wang J, Ma T, Yin C, Zhou L, Clausen BE, Mi QS, Jiang A

10.3390/vaccines12091037

TP20N


ß-Catenin in Dendritic Cells Negatively Regulates CD8 T Cell Immune Responses through the Immune Checkpoint Molecule Tim-3

Vaccines (Basel)

Fu C, Wang J, Ma T, Yin C, Zhou L, Clausen BE, Mi QS, Jiang A

10.3390/vaccines12050460

TP20N


Isolation and high-dimensional flow cytometric analysis of tumor-infiltrating leukocytes in a mouse model of colorectal cancer

Front Immunol

Eich C, Vogt JF, Längst V, Clausen BE, Hövelmeyer N

10.3389/fimmu.2024.1295863

TP20N


Constitutive expression of the deubiquitinating enzyme CYLD does not affect microglia phenotype or function in homeostasis and neuroinflammation

J Mol Med (Berl)

Schramm E, Becker V, Palagi I, Müller M, Rösler T, Durak F, Ebering A, Karram K, von Stebut E, Schmeisser MJ, Waisman A

10.1007/s00109-024-02489-7

TP15


Natural antibodies are required for clearance of necrotic cells and recovery from acute liver injury

JHEP Rep

Mattos MS, Vandendriessche S, Schuermans S, Feyaerts L, Hövelmeyer N, Waisman A, Marques PE

10.1016/j.jhepr.2024.101013

TP15, TP20N


A Th17 cell-instrinsic glutathione/mitochondrial-IL-22 axis protects against intestinal inflammation

Cell Metab

Bonetti L, Horkova V, Grusdat M, Longworth J, Guerra L, Kurniawan H, Franchina DG, Soriano-Baguet L, Binsfeld C, Verschueren C, Spath S, Ewen A, Koncina E, Gérardy JJ, Kobayashi T, Dostert C, Farinelle S, Härm J, Fan YT, Chen Y, Harris IS, Lang PA, Vasiliou V, Waisman A, Letellier E, Becher B, Mittelbronn M, Brenner D

10.1016/j.cmet.2024.06.010

TP15


Atypical MAPKs in cancer

FEBS J

Dahm K, Vijayarangakannan P, Wollscheid HP, Schild H, Rajalingam K

10.1111/febs.17283

TP05, TP13


CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells

Nat Commun

Bexte T, Albinger N, Al Ajami A, Wendel P, Buchinger L, Gessner A, Alzubi J, Särchen V, Vogler M, Rasheed HM, Jung BA, Wolf S, Bhayadia R, Oellerich T, Klusmann JH, Penack O, Möker N, Cathomen T, Rieger MA, Imkeller K, Ullrich E

10.1038/s41467-024-52388-1

TP12


Immune profiling and functional analysis of NK and T cells in ataxia telangiectasia

Front Immunol

Graafen L, Heinze A, Albinger N, Salzmann-Manrique E, Ganß F, Hünecke S, Cappel C, Wölke S, Donath H, Trischler J, Theilen TM, Heller C, Königs C, Ehl S, Bader P, Klingebiel T, Klusmann JH, Zielen S, Schubert R, Ullrich E

10.3389/fimmu.2024.1377955

TP12


CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients

Mol Cancer

Zöphel S, Küchler N, Jansky J, Hoxha C, Schäfer G, Weise JJ, Vialle J, Kaschek L, Stopper G, Eichler H, Yildiz D, Moter A, Wendel P, Ullrich E, Schormann C, Rixecker T, Cetin O, Neumann F, Orth P, Bewarder M, Hoth M, Thurner L, Schwarz EC

10.1186/s12943-024-02123-7

TP12


Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors

Mol Ther

Bexte T, Botezatu L, Miskey C, Gierschek F, Moter A, Wendel P, Reindl LM, Campe J, Villena-Ossa JF, Gebel V, Stein K, Cathomen T, Cremer A, Wels WS, Hudecek M, Ivics Z, Ullrich E

10.1016/j.ymthe.2024.05.022

TP12


Thunder-DDA-PASEF enables high-coverage immunopeptidomics and is boosted by MS2Rescore with MS2PIP timsTOF fragmentation prediction model

Nat Commun

Gomez-Zepeda D, Arnold-Schild D, Beyrle J, Declercq A, Gabriels R, Kumm E, Preikschat A, Łącki MK, Hirschler A, Rijal JB, Carapito C, Martens L, Distler U, Schild H, Tenzer S

10.1038/s41467-024-46380-y

TP13, Q01


Cytomegalovirus inhihbitors of programmed cell death restrict antigen cross-presentation in the priming of antiviral CD8 T cells

PLoS Pathog

Ebert S, Böhm V, Büttner JK, Brune W, Brinkmann MM, Holtappels R, Reddehase MJ, Lemmermann NAW

10.1371/journal.ppat.1012173

TP11


The effector program of human CD8 T cells supports tissue remodeling

J Exp Med

Delacher M, Schmidleithner L, Simon M, Stüve P, Sanderink L, Hotz-Wagenblatt A, Wuttke M, Schambeck K, Ruhland B, Hofmann V, Bittner S, Ritter U, Pant A, Helbich SS, Voss M, Lemmermann NA, Bessiri-Schake L, Bohn T, Eigenberger A, Menevse AN, Gebhard C, Strieder N, Abken H, Rehli M, Huehn J, Beckhove P, Hehlgans T, Junger H, Geissler EK, Prantl L, Werner JM, Schmidl C, Brors B, Imbusch CD, Feuerer M

10.1084/jem.20230488

TP19N


Microglia in retinal angiogenesis and diabetic retinopathy

Angiogenesis

Hu A, Schmidt MHH, Heinig N

10.1007/s10456-024-09911-1

TP09


The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases

Matrix Biol

Genovese F, Bager C, Frederiksen P, Vazquez D, Sand JMB, Jenkins RG, Maher TM, Stewart ID, Molyneaux PL, Fahy WA, Wain LV, Vestbo J, Nanthakumar C, Shaker SB, Hoyer N, Leeming DJ, George J, Trebicka J, Rasmussen DGK, Hansen MK, Cockwell P, Kremer D, Bakker SJ, Selby NM, Reese-Petersen AL, González A, Núñez J, Rossing P, Nissen NI, Boisen MK, Chen IM, Zhao L, Karsdal MA, Schuppan D

10.1016/j.matbio.2024.06.003

TP08


Acetylation of SAMHD11 at lysine 580 is crucial for blocking HIV-1 infection

mBio

Bulnes-Ramos A, Schott K, Rabinowitz J, Luchsinger C, Bertelli C, Miyagi E, Yu CH, Persaud M, Shepard C, König R, Kim B, Ivanov DN, Strebel K, Diaz-Griffero F

10.1128/mbio.01958-24

TP04


Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapy

Front Immunol

Bulashevska A, Nacsa Z, Lang F, Braun M, Machyna M, Diken M, Childs L, König R

10.3389/fimmu.2024.1394003

TP04


The ISG15 Protease USP18 Is a Pleiotropic Enhancer of HIV-1 Replication

Viruses

Lin C, Kuffour EO, Li T, Gertzen CGW, Kaiser J, Luedde T, König R, Gohlke H, Münk C

10.3390/v16040485

TP04


Proteolytic bacteria expansion during colitis amplifies inflammation through cleavage of the external domain of PAR2

Gut Microbes

Rondeau LE, Da Luz BB, Santiago A, Bermudez-Brito M, Hann A, De Palma G, Jury J, Wang X, Verdu EF, Galipeau HJ, Rolland C, Deraison C, Ruf W, Bercik P, Vergnolle N, Caminero A

10.1080/19490976.2024.2387857

TP02


Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer

Cancer cell

Calì B, Troiani M, Bressan S, Attanasio G, Merler S, Moscarda V, Mosole S, Ricci E, Guo C, Yuan W, Gallagher L, Lundberg A, Bernett I, Figueiredo I, Arzola RA, Abreut EB, D'Ambrosio M, Bancaro N, Brina D, Zumerle S, Pasquini E, Maddalena M, Lai P, Colucci M, Pernigoni N, Rinaldi A, Minardi D, Morlacco A, Moro FD, Sabbadin M, Galuppini F, Fassan M, Rüschoff JH, Moch H, Rescigno P, Francini E, Saieva C, Modesti M, Theurillat JP, Gillessen S, Wilgenbus P, Graf C, Ruf W, de Bono J, Alimonti A

10.1016/j.ccell.2024.08.018

TP10


Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination

Front Immunol

Heine A, Lemmermann NAW, Flores C, Becker-Gotot J, Garbi N, Brossart P, Kurts C

10.3389/fimmu.2024.1338499

Mit der Beteiligung von: TP11


Modulation of cytomegalovirus immune evasion identifies direct antigen presentation as the predominant mode of CD8 T-cell priming during immune reconstitution after hematopoietic cell transplantation

Front Immunol

Holtappels R, Büttner JK, Freitag K, Reddehase MJ, Lemmermann NA

10.3389/fimmu.2024.1355153

Mit der Beteiligung von: TP11


Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis-associated adhesion of ovarian cancer cells

Clin Transl Med 

Neuhaus F, Lieber S, Shinkevich V, Steitz AM, Raifer H, Roth K, Finkernagel F, Worzfeld T, Burchert A, Keber C, Nist A, Stiewe T, Reinartz S, Beutgen VM, Graumann J, Pauck K, Garn H, Gaida M, Müller R, Huber M

10.1002/ctm2.1604

Mit der Beteiligung von: TP22, TPQ1


Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients

Leukemia

Enssle JC, Campe J, Moter A, Voit I, Gessner A, Yu W, Wolf S, Steffen B, Serve H, Bremm M, Huenecke S, Lohoff M, Vehreschild M, Rabenau HF, Widera M, Ciesek S, Oellerich T, Imkeller K, Rieger MA, von Metzler I, Ullrich E

10.1038/s41375-023-02070-0

Mit der Beteiligung von: TP5, TP12


Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling

Blood

Zelaya H, Grunz K, Nguyen TS, Habibi A, Witzler C, Reyda S, Gonzalez-Menendez I, Quintanilla-Martinez L, Bosmann M, Weiler H, Ruf W

10.1182/blood.2023021149

Mit der Beteiligung von: TP02, TP10


Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development

Blood

Müller-Calleja N, Grunz K, Nguyen TS, Posma J, Pedrosa D, Meineck M, Hollerbach A, Braun J, Muth S, Schild H, Saar K, Hübner N, Krishnaswamy S, Royce J, Teyton L, Lemmermann N, Weinmann-Menke J, Lackner KJ, Ruf W

10.1182/blood.2023022276

Mit der Beteiligung von: TP02, TP11, TP13, TP21N


Immune damage in Long Covid

Science

Ruf W

10.1126/science.adn1077

Mit der Beteiligung von: TP02


TF-FVIIa PAR2-β-Arrestin Signaling Sustains Organ Dysfunction in Coxsackievirus B3 Infection of Mice

Arterioscler Thromb Vasc Biol

Kespohl M, Goetzke CC, Althof N, Bredow C, Kelm N, Pinkert S, Bukur T, Bukur V, Grunz K, Kaur D, Heuser A, Mülleder M, Sauter M, Klingel K, Weiler H, Berndt N, Gaida MM, Ruf W, Beling A

10.1161/ATVBAHA.123.320157

Mit der Beteiligung von: TP02, TP22N


ISG15 blocks cardiac glycolysis and ensures sufficient mitochondrial energy production during Coxsackievirus B3 infection

Cardiovasc Res

Bredow C, Thery F, Wirth EK, Ochs S, Kespohl M, Kleinau G, Kelm N, Gimber N, Schmoranzer J, Voss M, Klingel K, Spranger J, Renko K, Ralser M, Mülleder M, Heuser A, Knobeloch KP, Scheerer P, Kirwan J, Brüning U, Berndt N, Impens F, Beling A

10.1093/cvr/cvae026

Mit der Beteiligung von: TP02